Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys in Advanced Renal Cell Carcinoma
NCT00003542Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 1998
- Primary completion
- Apr 2004
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa in renal cell carcinoma (RCC), sponsored by Memorial Sloan Kettering Cancer Center. Started May 1998; status: completed.
02
Drugs
interferon alfa
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00003542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003542.